On Friday, Vor Biopharma Inc (NASDAQ: VOR) opened higher 51.55% from the last session, before settling in for the closing price of $0.84. Price fluctuations for VOR have ranged from $0.63 to $3.14 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 13.96% at the time writing. With a float of $59.88 million, this company’s outstanding shares have now reached $68.66 million.
In an organization with 168 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 77.63%, operating margin of -965.14%, and the pretax margin is -919.87%.
Vor Biopharma Inc (VOR) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Vor Biopharma Inc is 12.81%, while institutional ownership is 58.87%. The most recent insider transaction that took place on Dec 27 ’24, was worth 8,660. Before that another transaction happened on Jun 03 ’24, when Company’s CHIEF MEDICAL OFFICER sold 14,645 for $1.39, making the entire transaction worth $20,357. This insider now owns 96,063 shares in total.
Vor Biopharma Inc (VOR) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.3 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 13.96% per share during the next fiscal year.
Vor Biopharma Inc (NASDAQ: VOR) Trading Performance Indicators
Check out the current performance indicators for Vor Biopharma Inc (VOR). In the past quarter, the stock posted a quick ratio of 4.69.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.65, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -1.23 in one year’s time.
Technical Analysis of Vor Biopharma Inc (VOR)
Let’s dig in a bit further. During the last 5-days, its volume was 1.57 million. That was better than the volume of 0.53 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 45.05%. Additionally, its Average True Range was 0.10.
During the past 100 days, Vor Biopharma Inc’s (VOR) raw stochastic average was set at 100.00%, which indicates a significant increase from 100.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 203.17% in the past 14 days, which was higher than the 106.02% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8551, while its 200-day Moving Average is $1.1646. However, in the short run, Vor Biopharma Inc’s stock first resistance to watch stands at $1.3867. Second resistance stands at $1.5033. The third major resistance level sits at $1.7367. If the price goes on to break the first support level at $1.0367, it is likely to go to the next support level at $0.8033. The third support level lies at $0.6867 if the price breaches the second support level.
Vor Biopharma Inc (NASDAQ: VOR) Key Stats
There are currently 68,674K shares outstanding in the company with a market cap of 132.18 million. Presently, the company’s annual sales total 0 K according to its annual income of -117,863 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -27,559 K.
